Abstract
The health crisis triggered by the COVID-19 pandemic has challenged public management in several countries to ensure the timely and efficient procurement of the various health technologies necessary to cope with it, such as medicines, diagnostic tests, personal protective equipment (PPE) and medical materials/equipment, among others. This article introduces a protocol for a scoping review that aims to map and synthesize studies portraying the management capacity related to public procurement of inputs used in coping with the crisis arising from COVID-19. The protocol is intended to document the processes involved in the methodological planning and execution of a scoping review guided by Joanna Briggs Institute guidelines and developed using the 2015 PRISMA-Protocols (PRISMA-P) checklist. The PCC strategy (population, concept and context) systematized the search for studies published in MEDLINE, LILACS, Scopus, Embase, Web of Science and WHO-COVID-19 (Global literature on coronavirus disease), as well as in the gray literature, by September 2021. The selection of articles will be carried out in two steps (titles and abstracts, followed by the assessment of the full text of the articles), by two independent reviewers, with the resolution of disagreements by a third reviewer. The results will be analyzed qualitatively/quantitatively and will be organized by themes. The checklist present in the Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews (PRISMA-ScR) will be used to guide the final review report. The protocol was registered in the Open Science Framework under the number 10.17605/OSF.IO/W6KHY.
Highlights
Due to the spread of the new Coronavirus in several countries, the World Health Organization (WHO) declared a public health emergency of international importance on January 30th, 2020; and, subsequently, on March 11th, 2020, declared a pandemic situation in which refers to infection by the etiologic agent SARS-CoV-2 (Alves et al, 2020)
Given the emergency situation resulting from the global crisis, an adverse, uncertain and complex scenario was established that challenged the public management of several countries to ensure the efficient procurement of health technologies during the fight against the pandemic, which involves medicines, diagnostic tests, personal protective equipment (PPE) and medical materials/equipment, among others
This paper represents the scoping review planning protocol to map and synthesize studies published in the scientific and gray literature portraying management capacity related to public procurement of medicines, diagnostic tests, medical materials/equipment and PPE used in coping with the crisis arising from COVID-19
Summary
Due to the spread of the new Coronavirus in several countries, the World Health Organization (WHO) declared a public health emergency of international importance on January 30th, 2020; and, subsequently, on March 11th, 2020, declared a pandemic situation in which refers to infection by the etiologic agent SARS-CoV-2 (Alves et al, 2020). The development of management actions on public procurement is not a trivial task, because it depends on a succession of chained steps, requiring from the buyer a broad view of the health context, in addition to more specific knowledge, linked to the administrative, legal, economic and technical dimensions Such aspects provide greater agility in the procurement process, the achievement of competitive prices and the guarantee of the quality of the products to be purchased (Osorio-de-Castro et al, 2014). Public sector procurement is central to adequately responding to crisis situations, such as the new coronavirus pandemic, and requires governments to have the ability to select and assemble the necessary materials at short notice to trigger effective delivery of government services (Atkinson et al, 2020) In this context, the purchase may run into difficulties, in view of the increase in demand, the low availability of raw materials of manufacturing inputs and finished products, besides the increase in prices (Amaya et al, 2021; Gaudette, 2020). This paper represents the scoping review planning protocol to map and synthesize studies published in the scientific and gray literature portraying management capacity related to public procurement of medicines, diagnostic tests, medical materials/equipment and PPE used in coping with the crisis arising from COVID-19
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
